Deoxynucleoside modified ruthenium complex, and preparation method and use thereof
US-2024124514-A1 · Apr 18, 2024 · US
US9751910B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9751910-B2 |
| Application number | US-201414898741-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jul 3, 2014 |
| Priority date | Aug 13, 2013 |
| Publication date | Sep 5, 2017 |
| Grant date | Sep 5, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention relates to a method for preparing metal nanostructures using DNA, and more particularly, to a method for preparing metal nanostructures, in which a self-assembling DNA is used as a frame, and thus the orientation, shape and size of the nanostructures are easily controlled compared to conventional bottom-up methods. Metal nanostructures prepared by the method show excellent localized surface plasmon resonance properties, and thus can be used as fluorescent substances in drug delivery, biomedical imaging, and supersensitive biosensors.
Opening claim text (preview).
The invention claimed is: 1. A method for preparing a biomolecule-based metal nanostructure, the method comprising the steps of: (a) forming a self-assembled monomolecular layer of a biomolecule on the surface of a metal nanoseed, thereby forming a metal nanoseed-biomolecule complex; and (b) growing a metal ion on the surface of the complex while reducing the metal ion with a reducing agent, wherein the metal nanoseed-biomolecule complex is prepared by the steps of: (i) binding a desthiobiotin-modified DNA to a streptavidin-modified magnetic particle to form a magnetic particle-DNA complex; (ii) binding the metal nanoseed to the DNA of the complex to form a magnetic particle-DNA-metal nanoseed complex; and (iii) adding a biotin solution to the magnetic particle-DNA-metal nanoseed complex to separate the bond between the magnetic particle and the DNA and remove the magnetic particle from the complex, thereby obtaining a metal nanoseed-DNA complex, wherein steps (i) to (iii) are repeatedly performed. 2. The method of claim 1 , wherein step (i) further comprises, after forming the magnetic particle-DNA complex, a step of adding the magnetic particle-DNA complex to a mixture solution of EDC and NHS to activate the DNA. 3. A method for preparing a biomolecule-based metal nanostructure, the method comprising the steps of: (a) forming a self-assembled monomolecular layer of a biomolecule on the surface of a metal nanoseed, thereby forming a metal nanoseed-biomolecule complex; and (b) growing a metal ion on the surface of the complex while reducing the metal ion with a reducing agent, wherein the metal nanoseed-biomolecule complex is prepared by the steps of: (i) treating the metal nanoseed surface with a dATP having a terminal disulfide group and an oligo(ethylene glycol) (OEG-OH) having a hydroxyl group to form a self-assembled monomolecular layer, thereby modifying the metal nanoseed surface; (ii) adding a thiol-terminated DNA to the metal nanoseed, and separating and removing the dATP from the metal nanoseed by a ligand exchange reaction, thereby preparing a metal nanoseed-DNA complex; and (iii) recovering the metal nanoseed-DNA complex by electrophoresis. 4. A method for preparing a biomolecule-based metal nanostructure, the method comprising the steps of: (a) forming a self-assembled monomolecular layer of a biomolecule on the surface of a metal nanoseed, thereby forming a metal nanoseed-biomolecule complex; and (b) growing a metal ion on the surface of the complex while reducing the metal ion with a reducing agent, wherein the metal nanoseed-biomolecule complex is prepared by the steps of: (i) inserting a DNA intercalating molecule into a plasmid DNA, followed by desalting to obtain a plasmid DNA solution; (ii) adding a metal nanoseed aqueous solution to the plasmid DNA solution to form a metal nanoseed-plasmid DNA complex; and (iii) treating the metal nanoseed- plasmid DNA complex with a buffer (pH 10-14). 5. The method of claim 4 , wherein the DNA intercalating molecule is 1-pyrenebutyric acid (PBA) or S-(2-[[4-(2-phenanthryl)butyl]amino]ethyl)hydrogen sulfurothioate). 6. The method of any one of claims 1 , 3 , and 4 , wherein the source of the metal ion is one selected from the group consisting of hydrogen tetrachloroaurate(III) (HAuCl 4 ), sodium tetrachloroaurate(III) (NaAuCl 4 ), gold(III) chloride (AuCl 3 ), and potassium gold(III) chloride (KAuCl 4 ). 7. The method of any one of claims 1 , 3 , and 4 , wherein the reducing agent is one selected from the group consisting of hydroxylamine (NH 2 OH), sodium diphenylamine sulfonate, ascorbic acid, and poly(allylamine) hydrochloride. 8. The method of any one of claims 1 , 3 , and 4 , wherein the method further comprises, after step (b), a step of adding mercaptopropionic acid to the complex to terminate the growth. 9. The method of any one of claims 1 , 3 , and 4 , wherein the metal nanoseed is any one selected from the group consisting of nanospheres, nanorods, nanoprisms and nanosheets, and has a size of 1-100 nm. 10. The method of any one of claims 1 , 3 , and 4 , wherein the metal nanoseed is made of any one selected from the group consisting of gold (Au), silver (Ag), platinum (Pt), palladium (Pd), copper (Cu), silicon (Si), germanium (Ge), aluminum (Al), and metal oxides. 11. The method of any one of claims 1 , 3 , and 4 , wherein the biomolecule is any one selected from the group consisting of single-stranded DNAs, double-stranded DNAs, DNA oligomers, RNA oligomers, plasmid DNAs, polypeptides, and proteins, in which the single-stranded DNAs, the double-stranded DNAs, the DNA oligomers and the RNA oligomers are 5-5,000 bp in length, and the plasmid DNAs are 800-10,000 bp in length.
Nanosized particles · CPC title
Metallic powder coated with organic material · CPC title
Composition of gel or of carrier mixture · CPC title
Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy · CPC title
Manufacture or treatment of nanostructures · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.